Answer to the Letter to the Editor: Methotrexate in interstitial lung disease associated with rheumatoid arthritis

Reumatol Clin (Engl Ed). 2022 Aug-Sep;18(7):440-441. doi: 10.1016/j.reumae.2020.12.001. Epub 2021 Jul 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arthritis, Rheumatoid* / complications
  • Arthritis, Rheumatoid* / drug therapy
  • Humans
  • Lung Diseases, Interstitial* / complications
  • Methotrexate / adverse effects

Substances

  • Methotrexate